EVENTS · ILMN
PEERS
EARNINGS
Illumina Inc. is a global genomics and life sciences company that develops DNA sequencing and array-based technologies used to analyze genetic variation and biological function. Its products and systems support research, clinical testing, and applied markets across areas such as oncology, inherited and infectious diseases, reproductive health, and molecular diagnostics. Illumina also provides sequencing consumables, instruments, software, and support services that help laboratories generate, interpret, and manage genomic data. The company serves customers including academic institutions, genomic research centers, hospitals, pharmaceutical and biotechnology companies, and clinical laboratories. Headquartered in San Diego, California, and founded in 1998, Illumina plays a central role in making genomic analysis more widely accessible for research and healthcare applications.
No company news, with the diagnostics and research group modestly lower overall
| Series | 1W | 1M |
|---|---|---|
| ILMN | −21.5% | −17.1% |
| Peers | −0.7% | +10.3% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 2 | 9 |
| QUARTER | EPS EST | EPS ACTUAL | EPS SURPRISE | REACTION |
|---|---|---|---|---|
| Q3 FY2026 | 1.36 | 1.44 | +5.88% | −18.28% |
| Q2 FY2026 | 1.25 | 1.31 | +4.74% | +5.28% |
| Q1 FY2026 | 1.08 | 1.15 | +6.94% | +12.80% |
| Q4 FY2025 | 1.25 | 1.35 | +7.62% | −10.78% |
| Q3 FY2025 | 1.19 | 1.34 | +12.65% | +30.00% |
| Series | 1W | 1M |
|---|---|---|
| ILMN | −21.5% | −17.1% |
| Peers | −0.7% | +10.3% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 2 | 9 |
